Floatz logo

Vrp-Encapsulated Sarna Encoding Il-12

HNSCC

VLP Therapeuticsgene_therapyPhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

20 Active assets in the HNSCC cohort.

Asset / SponsorPhaseRating
Metformin
Dan Zandberg
Phase 2B
Letrozole
Dan Zandberg
Phase 2B
Eftilagimod Alfa
Immutep S.A.S.
Phase 2B
Carbon Nanoparticle Suspension
Sichuan Enray Pharmaceutical Sciences Company
Phase 2CCC
Rosiglitazone
Dan Zandberg
Phase 2CCC

View all 24 →

Same molecule, other indications

Vrp-Encapsulated Sarna Encoding Il-12 is also rated in:

head and neck squamous cell carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
Head Neck CancerDormant
CC
Indicative ·
43 / 100
View asset →
squamous cell carcinomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →